Eli Lilly & Co. (LLY)

107.22
0.43 0.40
NYSE : Health Technology
Prev Close 106.79
Open 106.92
Day Low/High 105.87 / 107.36
52 Wk Low/High 88.17 / 132.13
Volume 2.89M
Avg Volume 4.19M
Exchange NYSE
Shares Outstanding 970.83M
Market Cap 105.18B
EPS 3.10
P/E Ratio 41.67
Div & Yield 2.58 (2.26%)
Cramer: The Answer to This Market: Part 1

Cramer: The Answer to This Market: Part 1

The leadership is quite stark.

Intermediate Level Trade: Eli Lilly

Intermediate Level Trade: Eli Lilly

Consider that the $70 line of support.

Cramer: 3 Stocks Say Interest Rates Are Going Higher

Cramer: 3 Stocks Say Interest Rates Are Going Higher

Be aware that Johnson & Johnson, American Electric Power and Federal Realty don't roll over idly.

Are We Sitting Atop Another 8-Year Peak?

Are We Sitting Atop Another 8-Year Peak?

The market action looks very much like it did before the drops that occurred in 2000 and 2008.

Here Is Jim Cramer's Take on Eli Lilly Shares

Here Is Jim Cramer's Take on Eli Lilly Shares

Jim Cramer says Eli Lilly has been overpromising and underdelivering.

Why I Feel Bearish About the Market

Why I Feel Bearish About the Market

I'm not inclined to make market calls, but the action on my screen is pushing me to a defensive stance.

Watch the $78 Level on Eli Lilly

Watch the $78 Level on Eli Lilly

If buyers don't appear around $78 then a deeper correction is likely.

Trending Tickers: ORCL, N, FB, BA, LLY

Trending Tickers: ORCL, N, FB, BA, LLY

Facebook continued to reap the rewards of its strong quarterly results today.

Eli Lilly numbers raised at BMO

Midday Report: New Home Sales Highest Since 2008; U.S. Stocks Mixed

Midday Report: New Home Sales Highest Since 2008; U.S. Stocks Mixed

U.S. stocks retreat into the red as a number of positive and negative earnings reports keep trading choppy.

Cramer: Here's What's Really Behind This Hatred for Biotechs

This is the group that is the most dangerous politically.

Lilly's Charts Don't Prescribe an Outright Buy

Our quantitative service has upgraded the drug maker to a buy, but the technicals are not ready yet to join in.

LLY Investor Mtg.

2 Promising Biopharmas Reach Key Junctures

2 Promising Biopharmas Reach Key Junctures

FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.

BofA/Merrill Healthcare Conf.

LLY Investor Mtg.

Midday Report: Consumer Sentiment Falls; U.S. Stocks See Choppy Trade

Midday Report: Consumer Sentiment Falls; U.S. Stocks See Choppy Trade

U.S. stocks lose earlier highs on Tuesday as the health care sector pulls the markets lower.

2 Small-Cap Stocks That Could Win Big

2 Small-Cap Stocks That Could Win Big

Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.

Eli Lilly Revenue Beats, Facebook to Launch new Camera App

Eli Lilly Revenue Beats, Facebook to Launch new Camera App

Eli Lilly earnings came in short by 2 cents but revenue was slightly higher than estimates.

Jim Cramer: How Long Will the Bear Market in Biotech Continue?

Jim Cramer: How Long Will the Bear Market in Biotech Continue?

TheStreet's Jim Cramer isn't too fond of the pharmaceutical sector and he doesn't see that changing anytime soon.

Jim Cramer Is Bullish on Salesforce.com and Palo Alto Networks

Jim Cramer Is Bullish on Salesforce.com and Palo Alto Networks

TheStreet's Jim Cramer is on the floor of the NYSE talking MLB's Opening Day and answering social media questions.

Intermediate Trade: Eli Lilly

Intermediate Trade: Eli Lilly

Consider the LLY out-of-the-money, bearishly biased vertical put spread expiring in May.

Jim Cramer Says Eli Lilly’s Pipeline Is 'Challenged'

Jim Cramer Says Eli Lilly’s Pipeline Is 'Challenged'

TheStreet's Jim Cramer is concerned about what Eli Lilly has in its pipeline of new prospects.

Jim Cramer Likes Johnson & Johnson Over Eli Lilly in Pharma Sector

Jim Cramer Likes Johnson & Johnson Over Eli Lilly in Pharma Sector

TheStreet's Jim Cramer says Gilead (GILD) needs to make an acquisition to jump start its business.

That Was the Week That Was

That Was the Week That Was

Let's review.

CLOSED: Intermediate Trade: Eli Lilly

CLOSED: Intermediate Trade: Eli Lilly

Closing this trade now as gains are sweet and should be locked in.

Jim Cramer Says Avoid Airlines on Capacity Woes, Buy Eli Lilly

Jim Cramer Says Avoid Airlines on Capacity Woes, Buy Eli Lilly

TheStreet’s Jim Cramer commented on United Airlines and JetBlue on Tuesday from the floor of the New York Stock Exchange.

Jim Cramer Says Take a Long Term View on Healthcare Stocks

Jim Cramer Says Take a Long Term View on Healthcare Stocks

Jim Cramer says healthcare companies will be in the spotlight this week and investors should take a long term view of the sector if the stocks selloff.

Eli Lilly numbers increased at Leerink

What's Ahead Thursday: Why Investors Will Be Watching Eli Lilly

What's Ahead Thursday: Why Investors Will Be Watching Eli Lilly

In 'What's Ahead on Wall Street' for Thursday January 28, there are lots of earnings on tap but TheStreet highlights a few major ones.